TLX

Announcements

Nothing here yet

Daily updates

• Telix agreed to acquire ITM Isotope Technologies Munich for $1.65 billion upfront plus up to $700 million in milestones tied to ITM-11, adding commercial-scale radioisotope manufacturing and global lutetium-177 production capabilities.Sep 21, 2026

FDA designations

Nothing here yet

News

• Telix and ITM announced a strategic collaboration to build a radiopharmaceutical powerhouseSep 21, 2026
• FDA approved Telix's Pixclara brain cancer imaging drugSep 14, 2026
• TLX101-Tx IPAX-2 first-line glioblastoma study completes enrollment and confirms dosingMay 19, 2026
• New publication demonstrated the potential of TLX250-Px in diagnosing kidney cancers beyond ccRCCMay 5, 2026
• TLX101-Px (Pixlumi) marketing authorization application was accepted in EuropeMay 1, 2026